Mingjiang Xu

8.2k citations

101 papers · 4.4k indexed · 1 hit paper · h-index 34

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 58
- Acute Myeloid Leukemia Research 37
- Chronic Myeloid Leukemia Treatments 16
Genetics 37
- Myeloproliferative Neoplasms: Diagnosis and Treatment 36

Co-authors: Feng‐Chun Yang Ronald Hoffman Jiapeng Wang Chen‐Leng Cai Takefumi Ishii E Bruno Bruce Petersen Zhe Li
Journals: Blood (30 papers)Experimental Hematology (6 papers)Nature Communications (4 papers)Leukemia (4 papers)Journal of Clinical Investigation (3 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Mingjiang Xu

97 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies 2011 · 507 citations

Peers

Countries citing papers authored by Mingjiang Xu

Since Specialization

Citations

This map shows the geographic impact of Mingjiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiang Xu more than expected).

Fields of papers citing papers by Mingjiang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiang Xu. The network helps show where Mingjiang Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mingjiang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingjiang Xu Line = papers co-authored together Mingjiang Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models Journal of Clinical Investigation ·Guo Ge, Peng Zhang, 邦博仲谷, Dayane Batrov, Gregory Roche, Ying Guo, KAROLAYNE APARECIDA GUIMARÃES, Chloe O’Connell, Pëllumb Xhufi, Saud Abdulrahman Saad Alghamdi, Hui Geng, Edward A. Medina, Ying Liang, Stephen D. Nimer, Ruben A. Mesa, Omar Abdel‐Wahab, Mingjiang Xu, Feng‐Chun Yang	2023	3
2	Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping EMBO Reports ·Gregory Roche, 邦博仲谷, Ying Guo, Dayane Batrov, Titi Tania Hessi Y, Guo Ge, Jackeline Elizabeth Astudillo Rivera, Pëllumb Xhufi, Ganqian Zhu, Peng Zhang, Zhenqing Ye, Edward A. Medina, Nagi G. Ayad, Ruben A. Mesa, Stephen D. Nimer, Cheng‐Ming Chiang, Mingjiang Xu, Yidong Chen, Feng‐Chun Yang	2023	14
3	TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells Nucleic Acids Research ·Aruna S. Jaiswal, Arijit Dutta, Gayathri Srinivasan, Yaxia Yuan, Daohong Zhou, Montaser Shaheen, Philippe . Commissaire-priseur Delorme, Mehryar Keshavarz, Elizabeth A. Williamson, Yogesh K. Gupta, Shaun K. Olsen, Mingjiang Xu, Eva Loranc, Andi Irma Aryanti, Alexander Pertsemlidis, Alexander J.R. Bishop, Patrick Sung, Jac A. Nickoloff, Robert Hromas	2023	10
4	INTS11 regulates hematopoiesis by promoting PRC2 function Science Advances ·Peng Zhang, 邦博仲谷, Dayane Batrov, Ying Guo, Ying Li, Guo Ge, Ganqian Zhu, Gregory Roche, Cody M. Rogers, Patrick Sung, Stephen D. Nimer, Mingjiang Xu, Feng‐Chun Yang	2021	9
5	IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors Clinical Cancer Research ·Remco J. Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, Mohammed Khurshed, Marc-André. Leboeuf, Hideki Makishima, Mingjiang Xu, Fonnet E. Bleeker, Johanna W. Wilmink, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Cornelis J.F. Van Noorden, Jaroslaw P. Maciejewski	2018	79
6	Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC) Genomics Proteomics & Bioinformatics ·Yajing Chu, Zhigang Zhao, David Sant, Ganqian Zhu, Sarah Greenblatt, Lin Liu, Jinhuan Wang, Mark F. McDougal, Maryanne L. Campbell, Shi Chen, Xiaochen Liu, Peng Zhang, Jaroslaw P. Maciejewski, Stephen D. Nimer, Gaofeng Wang, Weiping Yuan, Feng‐Chun Yang, Mingjiang Xu	2018	18
7	Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis Nature Communications ·Xuekun Li, Bing Yao, Li Chen, Yunhee Kang, Yujing Li, Ying Cheng, Liping Li, Lin Li, Zhiqin Wang, Mengli Wang, Feng Pan, Qing Dai, Wei Zhang, Hao Wu, Qiang Shu, Zhaohui Qin, Chuan He, Mingjiang Xu, Peng Jin	2017	81
8	TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2-Driven Myeloid Malignancy Progression Stem Cell Reports ·Natalia Anatolevna Loginova, Yuan Zhou, Mark F. McDougal, Lin Liu, Jinhuan Wang, Zizhen Chen, Wen Xing, Shi Chen, Jie Bai, Weiping Yuan, Tao Cheng, Mingjiang Xu, Feng‐Chun Yang, Zhigang Zhao	2017	35
9	Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia PubMed ·Yun Chen, Yihang Pan, 何宗英, Wanke Zhao, Wan‐Ting Ho, Jianlong Wang, Mingjiang Xu, Feng‐Chun Yang, Zhizhuang Joe Zhao	2017	35
10	Loss of p300 accelerates MDS-associated leukemogenesis Leukemia ·Cheng Ge, K.S. Kwati, Takashi Asai, Fan Lai, Na Man, Huiling Xu, Marcelo De Brito Valadares, Sarah Greenblatt, Pierre-Jacques Hamard, Koji Ando, آذر مجدانیان, Emmanouil Andreas Evangelakos, Camilo Martinez, Madhavi Tadi, Liuyang Wang, Mingjiang Xu, Moritz A. Junker, Ramin Shiekhattar, Stephen D. Nimer	2016	28
11	Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice PMC ·Yan Li, Wen Xing, Yongzheng He, Shi Chen, Steven D. Rhodes, Jin Yuan, Yuan Zhou, Jun Shi, Jie Bai, Yongsuk Zarski, Weiping Yuan, Tao Cheng, Mingjiang Xu, Feng‐Chun Yang	2014	2
12	Rictor/mammalian target of rapamycin 2 regulates the development of notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3 Experimental Hematology ·Chunlan Hua, Huidong Guo, Jiachen Bu, Mi Zhou, Hui Cheng, Fuhong He, Jinhong Wang, Xiaomin Wang, A Postner, Qianfei Wang, Jianfeng Zhou, Tao Cheng, Mingjiang Xu, Weiping Yuan	2014	13
13	Genetic Evidence for Critical Roles of P38α Protein in Regulating Mast Cell Differentiation and Chemotaxis through Distinct Mechanisms Journal of Biological Chemistry ·Ping Hu, Nadia Carlesso, Mingjiang Xu, Yan Liu, Ángel R. Nebreda, Clifford M. Takemoto, Reuben Kapur	2012	14
14	The Effect of CXCL12 Processing on CD34+ Cell Migration in Myeloproliferative Neoplasms Cancer Research ·五十君清司, Mingjiang Xu, John Roboz, Min Lü, John Mascarenhas, Ronald Hoffman	2010	55
15	Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells Blood ·Min Lü, Jiapeng Wang, Yan Li, Dmitriy Berenzon, Xiaoli Wang, John Mascarenhas, Mingjiang Xu, Ronald Hoffman	2010	22
16	Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders Blood ·Takefumi Ishii, Jiapeng Wang, Wei Zhang, John Mascarenhas, Ronald Hoffman, Ying Dai, Nathaniel Wisch, Mingjiang Xu	2009	67
17	Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania Cancer Epidemiology Biomarkers & Prevention ·Vincent Seaman, Aisha O. Jumaan, Emad Yanni, Brian Lewis, Felipe Miguel, D. Shiferaw, Mingjiang Xu, Ronald Hoffman	2009	13
18	Correction of the Abnormal Trafficking of Primary Myelofibrosis CD34+ Cells by Treatment with Chromatin-Modifying Agents Cancer Research ·Xiaoli Wang, Wei Zhang, Takefumi Ishii, Selçuk Sözer, Jiapeng Wang, Mingjiang Xu, Ronald Hoffman	2009	30
19	The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome Blood ·Selçuk Sözer, Maria Isabel Fiel, Thomas D. Schiano, Mingjiang Xu, John Mascarenhas, Ronald Hoffman	2009	134
20	Is bone marrow fibrosis the real problem? Blood ·Ronald Hoffman, Mingjiang Xu	2006	4

About Mingjiang Xu

Mingjiang Xu is a scholar working on Hematology, Genetics, Rheumatology, Cancer Research and Molecular Biology, having authored 101 papers that have together received 4.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (37 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Eosinophilic Disorders and Syndromes (21 papers), Epigenetics and DNA Methylation (16 papers), Chronic Myeloid Leukemia Treatments (16 papers), RNA Research and Splicing (10 papers), Cancer-related molecular mechanisms research (9 papers) and Kruppel-like factors research (9 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (1.5k citations), Molecular Biology (3.0k citations), Rheumatology (585 citations) and Cancer Research (499 citations). Mingjiang Xu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Feng‐Chun Yang, Ronald Hoffman, Jiapeng Wang, Chen‐Leng Cai, Takefumi Ishii, E Bruno, Bruce Petersen, Zhe Li, Xiaoqiang Cai and John Mascarenhas. Their work appears in journals such as Blood, Experimental Hematology, Nature Communications, Leukemia and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact